Reimbursement for orphan drug Spinraza imminent

18 March 2019 - Biogen’s Spinraza (nusinersen), a treatment for spinal muscular atrophy, is likely to obtain reimbursement as early ...

Read more →

Korea’s 30th novel drug K-Cab to get insurance benefit from March

27 February 2019 - Korea’s 30th novel medicine K-Cab Tab. (tegoprazan) will receive insurance coverage, eight months after winning approval, the ...

Read more →

Lung cancer second treatment Alunbrig likely to get insurance coverage

25 February 2019 - The National Health Insurance Service’s drug price assessment committee recently evaluated Takeda’s Alunbrig (briganitib) as eligible ...

Read more →